FSTL3

FSTL3

Target · Secreted glycoprotein

FSTL3 Follistatin like 3 · Follistatin-related protein 3

FSTL3 (follistatin like 3, also known as FLRG or FSRP) is a secreted glycoprotein of the follistatin-module-protein family. It binds and antagonises members of the TGF-beta family, including activin, BMP2 and myostatin. Browse Assay Genie's current range of FSTL3 research reagents below, or read on for the biology behind the target.

Secreted and nuclearTGF-beta family antagonistPossible role in leukemogenesis
263 aa
Protein length
~28 kDa
Molecular weight
19p13.3
Gene locus
Follistatin-like
Protein family
Target information

What is FSTL3 (follistatin like 3)?

FSTL3 is a secreted glycoprotein that belongs to the follistatin-module-protein family. In its secreted form (isoform 1), it acts as a binding and antagonising protein for members of the TGF-beta family, such as activin, BMP2 and MSTN. By binding these ligands it inhibits activin A-, activin B-, BMP2- and MSTN-induced cellular signalling, and it is more effective against activin A than against activin B.

Beyond ligand antagonism, the secreted protein is involved in bone formation and inhibits osteoclast differentiation. It is also implicated in haematopoiesis: it takes part in the differentiation of haematopoietic progenitor cells, increases haematopoietic cell adhesion to fibronectin and appears to contribute to the adhesion of haematopoietic precursor cells to the bone marrow stroma. A second isoform (isoform 2) is found in the nucleus and is probably involved in transcriptional regulation through interaction with MLLT10.

The FSTL3 gene is also known as FLRG and FSRP, and was previously named follistatin-like 3 (secreted glycoprotein). The mouse and rat orthologs are both designated Fstl3. NCBI Gene notes that the protein may have a role in leukemogenesis, which makes it of interest in studies of blood cell development and disease alongside its established function as a regulator of TGF-beta family signalling.

TGF-beta family signalling

FSTL3 antagonises activin A, activin B, BMP2 and myostatin signalling, making it a useful target for studying regulation of TGF-beta family ligands.

Bone biology

The secreted protein is involved in bone formation and inhibits osteoclast differentiation, relevant to studies of bone remodelling.

Haematopoiesis research

FSTL3 influences haematopoietic progenitor differentiation and adhesion to fibronectin and the bone marrow stroma.

Leukaemia and transcription

FSTL3 may have a role in leukemogenesis, and its nuclear isoform probably regulates transcription through MLLT10.

Background

FSTL3 frequently asked questions

What does FSTL3 do?

Secreted FSTL3 binds and antagonises TGF-beta family members such as activin, BMP2 and myostatin, inhibiting their signalling. It is involved in bone formation, inhibits osteoclast differentiation and contributes to haematopoiesis, including progenitor differentiation and adhesion to fibronectin and the bone marrow stroma.

What other names and isoforms does FSTL3 have?

FSTL3 (follistatin like 3) is also called FLRG and FSRP, and was formerly named follistatin-like 3 (secreted glycoprotein). UniProt describes a secreted isoform 1 that antagonises TGF-beta family ligands, and a nuclear isoform 2 probably involved in transcriptional regulation via MLLT10.

Is FSTL3 conserved and linked to disease?

Orthologs exist in mouse and rat, both named Fstl3. NCBI Gene states that FSTL3 may have a role in leukemogenesis. Check the datasheet of any product for its validated reactivity.

Explore

Related targets

Other TGF-beta family ligands, follistatin-related proteins and bone and haematopoiesis markers linked to FSTL3 biology.

Gene and protein annotations from HGNC, NCBI Gene and UniProt O95633; product specifications from Assay Genie datasheets.

FSTL3 Product listing